Publications by authors named "C Halimi"
Article Synopsis
- * The study found that MSCs influence microglia, the brain's immune cells, to adopt pro-regenerative functions by altering the extracellular matrix in response to inflammation.
- * Key findings showed that MSC secretome leads to changes in microglial behavior, enhancing their mobility and cellular structures, which are important for promoting healing in the brain.
Article Synopsis
- Susac syndrome is a rare disease primarily affecting young women, characterized by occlusive microvessel issues in the brain, retina, and inner ear, and lacks established treatment protocols from randomized trials.
- The study investigated the effectiveness of glucocorticoids alone or with other immunosuppressive treatments for preventing relapses in Susac syndrome, and involves a national cohort of patients recruited in France since 2011.
- Data were collected on various health indicators and treatments over a 36-month period to determine the first relapse, involving 64 patients, and the study is registered on ClinicalTrials.gov for transparency.
Use of perfusion device for free flap salvage after ischemia in swine.
Ann Chir Plast Esthet
September 2024
Introduction: In free flap reconstruction, improving flap tolerance to warm ischemia (WI) is fundamental. WI is the result of a venous or arterial thrombosis, which can only be addressed through surgical revision. No additional treatments have shown superior efficacy at salvaging free flaps after or during WI.
View Article and Find Full Text PDFBackground: Local infiltration analgesia (LIA) has been advocated for the pain management after total hip arthroplasty (THA). The analgesic benefits of an added pericapsular nerve group (PENG) block remain questionable.
Methods: This randomized, single-blind trial enrolled patients undergoing elective THA under general anaesthesia and standardized postoperative analgesia.
The emulsification potential of plant-based emulsifiers, that is, pea (PPI) and lentil (LPI) proteins (4%), corn arabinoxylans (CAX, 1%), and legume protein-arabinoxylan mixtures (4% proteins + 0.15 or 0.9% CAX), was evaluated by assessing: the surface tension and potential of emulsifiers, emulsifier antinutritional contents, emulsion droplet size, emulsion physical stability, and vitamin E bioaccessibility from 10% oil-in-water emulsions.
View Article and Find Full Text PDF